5LX6 - Sequence, Chains, Asymmetric and Biological Units

• Title: HUMAN PARP10 (ARTD10), CATALYTIC FRAGMENT IN COMPLEX WITH PA INHIBITOR VELIPARIB
• Keywords: TRANSFERASE DOMAIN, ADP-RIBOSYLATION, PARP INHIBITOR, TRANSF
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	5LX6	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	POLY [ADP-RIBOSE] POLYMERASE 10	A	191	1520	0
2	Protein	POLY [ADP-RIBOSE] POLYMERASE 10	B	189	1503	0
3	Ligand	POLY [ADP-RIBOSE] POLYMERASE 10	A	1	0	18
4	Ligand	POLY [ADP-RIBOSE] POLYMERASE 10	B	1	0	18
5	Water			360	0	360
total				742	3023	396

Proteins

Unit 1

SER 817 MET 818 ASN 819 LEU 820 GLU 821 ARG 822 LEU 823 ALA 824 GLU 825 ASN 826 THR 827 GLY 828 GLU 829 PHE 830 GLN 831 GLU 832 VAL 833 VAL 834 ARG 835 ALA 836 PHE 837 TYR 838 ASP 839 THR 840 LEU 841 ASP 842 ALA 843 ALA 844 ARG 845 SER 846 SER 847 ILE 848 ARG 849 VAL 850 VAL 851 ARG 852 VAL 853 GLU 854 ARG 855 VAL 856 SER 857 HIS 858 PRO 859 LEU 860 LEU 861 GLN 862 GLN 863 GLN 864 TYR 865 GLU 866 LEU 867 TYR 868 ARG 869 GLU 870 ARG 871 LEU 872 LEU 873 GLN 874 ARG 875 CYS 876 GLU 877 ARG 878 ARG 879 PRO 880 VAL 881 GLU 882 GLN 883 VAL 884 LEU 885 TYR 886 HIS 887 GLY 888 THR 889 THR 890 ALA 891 PRO 892 ALA 893 VAL 894 PRO 895 ASP 896 ILE 897 CYS 898 ALA 899 HIS 900 GLY 901 PHE 902 ASN 903 ARG 904 SER 905 PHE 906 CYS 907 GLY 908 ARG 909 ASN 910 ALA 911 THR 912 VAL 913 TYR 914 GLY 915 LYS 916 GLY 917 VAL 918 TYR 919 PHE 920 ALA 921 ARG 922 ARG 923 ALA 924 SER 925 LEU 926 SER 927 VAL 928 GLN 929 ASP 930 ARG 931 TYR 932 SER 933 PRO 934 PRO 935 ASN 936 ALA 937 ASP 938 GLY 939 HIS 940 LYS 941 ALA 942 VAL 943 PHE 944 VAL 945 ALA 946 ARG 947 VAL 948 LEU 949 THR 950 GLY 951 ASP 952 TYR 953 GLY 954 GLN 955 GLY 956 ARG 957 ARG 958 GLY 959 LEU 960 ARG 961 ALA 962 PRO 963 PRO 964 LEU 965 ARG 966 GLY 967 PRO 968 GLY 969 HIS 970 VAL 971 LEU 972 LEU 973 ARG 974 TYR 975 ASP 976 SER 977 ALA 978 VAL 979 ASP 980 CYS 981 ILE 982 CYS 983 GLN 984 PRO 985 SER 986 ILE 987 PHE 988 VAL 989 ILE 990 PHE 991 HIS 992 ASP 993 THR 994 GLN 995 ALA 996 LEU 997 PRO 998 THR 999 HIS 1000 LEU 1001 ILE 1002 THR 1003 CYS 1004 GLU 1005 HIS 1006 VAL 1007

Unit 2

ASN 819 LEU 820 GLU 821 ARG 822 LEU 823 ALA 824 GLU 825 ASN 826 THR 827 GLY 828 GLU 829 PHE 830 GLN 831 GLU 832 VAL 833 VAL 834 ARG 835 ALA 836 PHE 837 TYR 838 ASP 839 THR 840 LEU 841 ASP 842 ALA 843 ALA 844 ARG 845 SER 846 SER 847 ILE 848 ARG 849 VAL 850 VAL 851 ARG 852 VAL 853 GLU 854 ARG 855 VAL 856 SER 857 HIS 858 PRO 859 LEU 860 LEU 861 GLN 862 GLN 863 GLN 864 TYR 865 GLU 866 LEU 867 TYR 868 ARG 869 GLU 870 ARG 871 LEU 872 LEU 873 GLN 874 ARG 875 CYS 876 GLU 877 ARG 878 ARG 879 PRO 880 VAL 881 GLU 882 GLN 883 VAL 884 LEU 885 TYR 886 HIS 887 GLY 888 THR 889 THR 890 ALA 891 PRO 892 ALA 893 VAL 894 PRO 895 ASP 896 ILE 897 CYS 898 ALA 899 HIS 900 GLY 901 PHE 902 ASN 903 ARG 904 SER 905 PHE 906 CYS 907 GLY 908 ARG 909 ASN 910 ALA 911 THR 912 VAL 913 TYR 914 GLY 915 LYS 916 GLY 917 VAL 918 TYR 919 PHE 920 ALA 921 ARG 922 ARG 923 ALA 924 SER 925 LEU 926 SER 927 VAL 928 GLN 929 ASP 930 ARG 931 TYR 932 SER 933 PRO 934 PRO 935 ASN 936 ALA 937 ASP 938 GLY 939 HIS 940 LYS 941 ALA 942 VAL 943 PHE 944 VAL 945 ALA 946 ARG 947 VAL 948 LEU 949 THR 950 GLY 951 ASP 952 TYR 953 GLY 954 GLN 955 GLY 956 ARG 957 ARG 958 GLY 959 LEU 960 ARG 961 ALA 962 PRO 963 PRO 964 LEU 965 ARG 966 GLY 967 PRO 968 GLY 969 HIS 970 VAL 971 LEU 972 LEU 973 ARG 974 TYR 975 ASP 976 SER 977 ALA 978 VAL 979 ASP 980 CYS 981 ILE 982 CYS 983 GLN 984 PRO 985 SER 986 ILE 987 PHE 988 VAL 989 ILE 990 PHE 991 HIS 992 ASP 993 THR 994 GLN 995 ALA 996 LEU 997 PRO 998 THR 999 HIS 1000 LEU 1001 ILE 1002 THR 1003 CYS 1004 GLU 1005 HIS 1006 VAL 1007

Ligands

Unit 3	78P 1101
Unit 4	78P 1101